Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
50 hedge funds and large institutions have $64.9M invested in Psychemedics Corporation in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 21 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
9% more funds holding
Funds holding: 46 → 50 (+4)
3% more capital invested
Capital invested by funds: $62.8M → $64.9M (+$2.09M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
71% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 21
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q1 2018 in Review
50 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2018, worth a combined $64.9M — up 3.3% from $62.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PMD positions and 5 closed out — a net gain of 4 holders — while 6 added to existing stakes and 21 trimmed.
The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $1.15M. The largest seller was Granite Investment Partners, cutting an estimated $877K.
- 50 institutional investors held Psychemedics Corporation (PMD) as of Q1 2018, up from 46 in Q4 2017.
- Funds reported $64.9M of Psychemedics Corporation stock for Q1 2018, up 3.3% quarter-over-quarter.
- 9 funds opened new Psychemedics Corporation positions in Q1 2018 and 5 closed out, a net change of +4 holders.
- The largest Psychemedics Corporation buyer in Q1 2018 was Kennedy Capital Management, an estimated $1.15M added.
- The largest Psychemedics Corporation seller in Q1 2018 was Granite Investment Partners, an estimated $877K sold.
Based on aggregated 13F filings for Q1 2018.